Francesca Barone, Chief Scientific Officer at Candel Therapeutics, Inc. (CADL), sold 44,162 shares at $4.56 ($201K) on 2024-11-29, disclosed to the SEC on 2024-12-03.
Open-market sale of $201k CADL by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.56 | 22,081 | $101K | 50.0% |
| 2 | $4.56 | 22,081 | $101K | 50.0% |
| Total | $4.56 avg | 44,162 | $201K | 100% |
| Filing → |
| CADL | SELL | 2025-01-17 | $196K | — | Filing → |
| CADL | SELL | 2025-01-10 | $225K | — | Filing → |
| CADL | SELL | 2024-07-19 | $182K | — | Filing → |